Auricular Acupressure as a Non-Opioid Adjuvant in Opioid Tolerant Patients
CompletedNot applicableNCT05711537
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The purpose of this study is to determine if the addition of auricular acupressure to the typical pharmacological regimen given to patients on the chronic pain/addiction service will lower pain scores and decrease pain medication usage.
Study details
- Official title
- Auricular Acupressure as a Non-Opioid Adjuvant in Opioid Tolerant Patients
- Conditions
- Interventions
- Device: Auricular Acupressure with Vaccaria 600t ear seeds
- Sponsor
- Wake Forest University Health Sciences
- Start date
- 2023-04-17
- Primary completion
- 2023-06-02
- Sex
- All
- Age range
- from 18 Years
- Results posted
- Yes, on ClinicalTrials.gov
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Age \> or equal to 18 * History of documented chronic pain with or without opioid use disorder (Polysubstance abuse or opioid use disorder or opioid narcotic use documented as home medication) * Estimated length of stay (admission) at least 5 days at the time of recruitment * Able to read and understand informed consent form Exclusion Criteria: * Patient refusal * Patients with a known history of leaving against medical advice (AMA) * only English-speaking participants will be eligible. * Inability to communicate via telephone * Participants with a history of skin disease (e.g., psoriasis) involving the ear, adhesive allergy, recent scar tissue on ear, or current abrasions or cuts on ear, * Cognitive impairment (delirium, dementia) * Physical impairment preventing them from applying pressure to the beads * Patients with cardiac pacemakers (contraindication to POINTER PAL) * Use of some types of hearing aids (obstructing the placement of beads) * Any chronic or acute illness or psychiatric conditions that would impact adherence to the study requirements
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05711537